Chargement en cours...
Preparation for a first-in-man lentivirus trial in patients with cystic fibrosis
We have recently shown that non-viral gene therapy can stabilise the decline of lung function in patients with cystic fibrosis (CF). However, the effect was modest, and more potent gene transfer agents are still required. Fuson protein (F)/Hemagglutinin/Neuraminidase protein (HN)-pseudotyped lentivi...
Enregistré dans:
| Publié dans: | Thorax |
|---|---|
| Auteurs principaux: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
BMJ Publishing Group
2017
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5284333/ https://ncbi.nlm.nih.gov/pubmed/27852956 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/thoraxjnl-2016-208406 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|